Researchers look back to see which treatment works best for rare immune disease
NCT ID NCT02116764
Summary
This study looked back at the medical records of 137 patients with Chronic Granulomatous Disease (CGD), a rare immune disorder. It compared the long-term survival and health of patients who received a stem cell transplant to those who received standard medical care. The goal was to learn which patients benefit most from a transplant and what type of transplant works best.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC GRANULOMATOUS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.